Evidence map›Paper›PMID 41584269›Full record

ArticleKidney international reports2026

Regional Variation in Early Kidney Transplant Access Across Dialysis Facilities in 4 US Regions.

Jade Buford, Mengyu Di, Jessica L Harding, Kelsey Drewry, Catherine Kelty, Adam Wilk, Anne Huml, Ana P Rossi, Sumit Mohan, Bruce E Gelb and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jade BufordRegenstrief Institute, Indianapolis, Indiana, USA.
Mengyu DiRegenstrief Institute, Indianapolis, Indiana, USA.
Jessica L HardingEmory University, Atlanta, Georgia, USA.
Kelsey DrewryRegenstrief Institute, Indianapolis, Indiana, USA.
Catherine KeltyIndiana University, Indianapolis, Indiana, USA.
Adam WilkRegenstrief Institute, Indianapolis, Indiana, USA.
Anne HumlCleveland Clinic, Cleveland, Ohio, USA.
Ana P RossiPiedmont Transplant Institute, Atlanta, Georgia, USA.
Sumit MohanColumbia University, New York, New York, USA.
Bruce E GelbNYU Langone Health, New York, New York, USA.
Bhavna ChopraBeth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Daniel GlicklichWestchester Medical Center, New York Medical College, Valhalla, New York, USA.
Prince Mohan AnandMedical University of South Carolina, Lancaster, South Carolina, USA.
Matthew HandmacherErie County Medical Center, Buffalo, New York, USA.
Laura MulloyMedical College of Georgia at Augusta University, Augusta, Georgia, USA.
Wasim A DarHartford Hospital Comprehensive Transplant Center, Hartford, Connecticut, USA.
Amber Reeves-DanielWake Forest Medical Center, Atlanta, Georgia, USA.
Enver AkalinMontefiore Medical Center, Bronx, New York, USA.
Kenneth J McPartlandBaystate Medical Center, Kidney Transplant Program, Springfield, Massachusetts, USA.
Stephen O PastanEmory University, Atlanta, Georgia, USA.
Rachel E PatzerRegenstrief Institute, Indianapolis, Indiana, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pretransplant access varies, but whether pretransplant steps vary regionally across dialysis facilities remains unclear. Methods: We identified 62,467 adults (aged 18-80 years) referred from 2471 dialysis facilities and 27,171 initiating transplant evaluation from 2188 facilities in New England, New York, Southeast, and Ohio River Valley within the Early Steps to Transplant Access Registry (E-STAR) (January 1, 2015-December 31, 2023), linked with US Renal Data System (USRDS) and the Scientific Registry of Transplant Recipients data, followed-up through March 2, 2024. We examined dialysis facility-level proportions of evaluation start within 6 months of referral and waitlisting within 1 year of evaluation start. Descriptive statistics using analysis of variance and chi-square tests summarized outcome distributions and baseline characteristics within tertiles of outcome proportions, overall and by region. Results: Evaluation start within 6 months across 2471 facilities varied from 0% to 100%; median within-facility proportion was 50% (interquartile range: 33.3%-64.3%), ranging from 33.3% (18.2%-50%) in the Ohio River Valley to 66.7% (50%-76.7%) in New York. Waitlisting within 1 year of evaluation start varied from 0% to 100% across 2188 facilities; median within-facility proportion was 41.2% (26.0%-60%), lowest in the Southeast (31.9% [20%-43.8%]) and similar across other regions (50%). Facilities in the lowest tertile of evaluation start proportions (< 39.13%) more often treated patients from high-poverty neighborhoods (36.8% vs. 29.2%) and were for-profit (82.4% vs. 73.5%) than the highest tertile (> 58.33%). These characteristics varied by region. Facility-level clustering explained 12.2% (95% confidence interval [CI]: 10.5%-13.5%) of variation in evaluation and 8.2% (6.7%-9.2%) in waitlisting. Conclusion: Substantial regional variation in pretransplant access across dialysis facilities reinforces the need for region-specific strategies to improve access.

Indexed as

dialysis facilityevaluation startkidneykidney transplantationwaitlisting

Identifiers

PMID41584269
PMCPMC12828506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.